What Tamro does

Tamro AB is Sweden's market-leading independent pharmaceutical distributor, operating a Direct-to-Pharmacy (DTP) third-party logistics model in which pharmaceutical manufacturers assign Tamro to warehouse and transport their products directly to pharmacies. Founded in 1921 as ADA (Apotekarnes Droghandelsaktiebolag) and headquartered in Gothenburg, Tamro is wholly owned by the German Phoenix Group, a diversified European healthcare conglomerate operating in 27 countries with over 40,000 employees. Tamro processes approximately 5.4 million pharmaceutical orders annually, delivers daily to all 1,450 pharmacies in Sweden, and operates distribution centers and central warehouses in Gothenburg, Stockholm (Kungens Kurva), Umeå, Nykvarn, and Eskilstuna, supported by 800+ employees.

The company's core logistics platform combines temperature-controlled warehousing, GDP/GMP/FMD-compliant quality processes, repackaging, batch release, EU release, and Joint Audit services (with Scandinavian Regulatory Services). Beyond pure distribution, Tamro has built a portfolio of value-added digital and quality services: the Tamro BI Premium analytics platform (built on Qlik Sense with an AI Assistant add-on launched April 2026), the Generic Substitution Tool (launched June 2026), the Apoteksportalen pharmacy communication portal, email and "Blue Bag" outreach to pharmacies, FMD verification, temperature logging in transport, sample transport, and the Smila medication robot (a home-care digital dispenser). The Smila Gen 2 won the German Brand Awards UX Prize in 2025.

Tamro's go-to-market is enterprise field sales targeting pharmaceutical manufacturers for DTP contracts and direct relationships with Swedish pharmacy chains (Apoteket AB, Apotek Hjärtat, Lloyds apotek, Kronans Apotek, Apoteksgruppen) and Swedish regions/government health authorities for the National Pharmaceutical Stockpile and crisis-response logistics. Revenue is generated through managed-service contracts for warehousing and distribution, with add-on fees for analytics, repackaging, quality, and digital communication services. Pricing is not publicly disclosed and is negotiated on a per-customer contract basis. Recent strategic activity includes a new Eskilstuna central warehouse (2022), the Blue Ocean Sales Scandinavia AB acquisition (2019), the appointment of Mats Johnson as CEO (March 2023), and a series of 2026 digital product launches aimed at extending software-driven margin on top of the logistics core.

Name

Tamro

Legal name

Tamro AB

Website

https://tamro.se

Company type

Private

Founded year

1921

Operating status

Operating

Headcount range

251–500 employees

Short description

Tamro is Sweden's market-leading independent pharmaceutical distributor, operating a Direct-to-Pharmacy third-party logistics model serving pharmaceutical manufacturers and all 1,450 Swedish pharmacies with temperature-controlled warehousing, quality services, and a growing digital analytics platform.

Ownership category

akta.pro rank

Product category

Pharmaceutical Logistics Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals (HLAIAJAL)

akta.pro secondary industries

Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs) (TLAIAGAI), Managed Transportation Services (MTS) / Outsourced TMS Operations (TLAIAEAB)

Keywords

• Pharmaceutical distribution
• Cold chain logistics
• Direct-to-pharmacy services
• Healthcare logistics
• Pharmaceutical supply chain

Headquarters

HQ city

Gothenburg

HQ country

Sweden

HQ region

Europe

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D

Revenue model

1. Third-Party Logistics (TPL) — Direct-to-Pharmacy: Tamro operates as a third-party logistics provider under the Direct-to-Pharmacy (DTP) model. Pharmaceutical companies give Tamro the assignment to warehouse and transport all their medicines to pharmacies. This creates a unified flow that increases quality, safety, and efficiency while reducing costs. Tamro is not a traditional wholesaler but a third-party logistics company.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

Tamro is a third-party pharmaceutical logistics provider operating under the Direct-to-Pharmacy (DTP) model, warehousing and transporting medicines on behalf of pharmaceutical manufacturers for delivery to Sweden's 1,450 pharmacies, hospitals and healthcare facilities. Core services include temperature-controlled distribution, batch and EU release, repackaging, FMD verification, Joint Audits, Business Intelligence analytics, and the Smila medication robot for home-care medication management.

Product overview

Tamro is Sweden's leading independent pharmaceutical distribution company operating under a Direct-to-Pharmacy (DTP) model. The company offers a comprehensive suite of logistics and distribution services including core pharmaceutical distribution to all Swedish pharmacies, temperature-controlled transport services, and Business Intelligence analytics tools (built on Qlik Sense). The product portfolio includes the BI Premium analytics platform with an AI assistant add-on, the Generic Substitution Tool for inventory planning, the Apoteksportalen digital marketing platform, outreach services via email and blue bags to Sweden's 1,450 pharmacies, patient support and self-monitoring platforms (PACE project), the Smila medication robot (developed by JDM Innovation), quality services including Joint Audits with Scandinavian Regulatory Services, repackaging, temperature monitoring, FMD verification, batch release, and EU release. The company is part of the Phoenix Group and celebrated its 100th anniversary in 2021.

Differentiator

Problem solved

Functional benefit

Products and services

• Generic Substitution Tool Digital application that aggregates information about interchangeable products and period-of-supply (periodens vara) status to give customers better overview and planning support within generic substitution.
• Tamro Business Intelligence Premium Analytics and reporting platform for pharmaceutical companies providing sales statistics to wholesalers combined with other sales, up to 5 years of history, batch-level transaction information and deeper analyses for decision support.
• AI Assistant for Tamro BI Premium AI assistant add-on for Tamro BI Premium that supports faster decisions, better tracking and clearer overview of pharmaceutical distribution data.
• Apoteksportalen (Pharmacy Portal) Digital platform enabling pharmaceutical companies to reach pharmacy staff across Sweden with important information such as Medical Products Agency updates, article number changes or replacement products.
• Email Outreach to Pharmacies Service enabling customers to send offers, newsletters or information to pharmacies connected to Tamro, with targeting by all pharmacies, open-care pharmacies only or specific pharmacy chains.
• Outreach via Blue Bags Service allowing customers to send physical materials such as products and promotional items to Sweden's 1,450 pharmacies through Tamro's existing daily blue-bag delivery system.
• Direct-to-Pharmacy (DTP) Distribution Core logistics model where pharmaceutical companies give Tamro the assignment to warehouse and transport all their medicines to pharmacies, creating a unified flow that increases quality, safety and efficiency while reducing costs.
• Repackaging Services Comprehensive repackaging services including adding package leaflets for sale in other countries, control assignments for suspected defects, seal verification, readable 2D code verification, suspected leakage inspection, defect examination, weighing assignments and commercial goods repackaging.
• Temperature Logging in Transport Temperature monitoring service for temperature-sensitive medicines during transport, with automatic alerts for deviations and temperature logs available for both refrigerated and room temperature conditions.
• Temperature Control at Delivery Service verifying that temperature has been correct during transport, with options to read temperature logs, receive temperature curves by email, block goods if logs indicate deviations, and return reusable temperature loggers.
• Transport of Tests and Samples Transport service for samples and tests from pharmacies, health centres or other facilities to labs for analysis, performed in GDP-classified transports meeting temperature requirements for both room temperature and unbroken cold chain.
• FMD Verification Service Falsified Medicines Directive (FMD) verification of incoming delivered medicines, enabling early detection of incorrect or non-uploaded products and batches to prevent problems later in the supply chain.
• Joint Audits Collaborative audit service in partnership with Scandinavian Regulatory Services (SRS) where multiple customers coordinate audits simultaneously, reducing administration and costs while maintaining quality through certified auditors reviewing GDP, GMP and other quality requirements.
• Smila Medication Robot (Smila Gen 2) Digital medication robot developed by JDM Innovation that dispenses medication and reminds patients to take it at the right time, with dual medication compartments, fingerprint identification and missed-dose alerts, enabling remote medication management for home-care patients.
• PACE Patient Self-Monitoring Platform Vinnova-funded collaboration platform enabling self-monitoring within Swedish cancer care, creating interactivity between patient and inpatient care to improve cancer patient autonomy, safety and care efficiency, with participation from AbbVie, AstraZeneca, Bristol Myers Squibb, Janssen and Region Jönköpings Län.

Quantifiable outcome

• Tamro processes approximately 5.4 million pharmaceutical orders per year
• +4 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

15 partnerships are on record, tiered minor and core.

• Scandinavian Regulatory Services (SRS)minorImplementation/ SI/ Consulting Partner · 1 January 2026SRS provides certified auditors for Tamro's Joint Audit program, enabling coordinated customer audits that reduce administrative burden and costs while ensuring GDP and GMP compliance. Joint Audits are conducted at Tamro's facilities in Kungens Kurva, Eskilstuna, Umeå, and Gothenburg in 2026.
• Karo PharmaminorStrategic or Co-development Partner · 31 March 2022Karo Pharma partnered with Tamro to send urgent medical supply shipments to Ukraine as part of coordinated national efforts organized by the Swedish Medical Products Agency (Läkemedelsverket) and MSB.
• Läkemedelsverket (MPA) & MSBcoreStrategic or Co-development Partner · 31 March 2022Swedish Medical Products Agency and Swedish Civil Contingencies Agency coordinated national efforts with Tamro to send pharmaceutical aid shipments to Ukraine. Tamro acted as a logistics partner in this government-coordinated humanitarian effort.
• AbbViecoreStrategic or Co-development Partner · 3 February 2022Tamro and AbbVie are part of a unique collaboration (along with AstraZeneca, Bristol Myers Squibb, and Janssen) to strengthen the conditions for self-monitoring in cancer care. The PACE project aims to enable patients to access self-monitoring, create a cross-industry learning arena, and ensure patient-reported data is comparable and accessible. Funded by Vinnova through Swelife and Medtech4Health programs.
• AstraZenecacoreStrategic or Co-development Partner · 3 February 2022Part of the PACE collaboration with Tamro, AbbVie, Bristol Myers Squibb, and Janssen to promote eGFR/eHealth monitoring in cancer care in Sweden. AstraZeneca contributes as a pharmaceutical industry partner in this multi-stakeholder initiative.
• Bristol Myers SquibbcoreStrategic or Co-development Partner · 3 February 2022Part of the PACE collaboration with Tamro to strengthen eHealth self-monitoring in Swedish cancer care. Bristol Myers Squibb joins AbbVie, AstraZeneca, and Janssen in this industry-wide partnership.
• Janssen (Johnson & Johnson)coreStrategic or Co-development Partner · 3 February 2022Part of the PACE collaboration with Tamro, AbbVie, AstraZeneca, and Bristol Myers Squibb to advance self-monitoring in Swedish cancer care.
• LBC FraktminorStrategic or Co-development Partner · 21 October 2021Freight company partnering with Tamro for greener pharmacy transports. Collaboration includes using HVO100 diesel (70% CO2 reduction) and biogas trucks, projected to reduce emissions by 6 tonnes CO2/month plus an additional 103 tonnes/year.
• TGM ABminorStrategic or Co-development Partner · 18 May 2021Transport company (carrier for DB Schenker) partnering with Tamro to test Volvo FL Electric — Volvo's first fully electric truck. The test involved deliveries from Tamro's distribution warehouse in Hisings Backa for inner-city Gothenburg routes.
• Region Jönköpings LäncoreStrategic or Co-development Partner · 8 April 2021Project partner in the PACE Vinnova-funded initiative led by Tamro. Region Jönköpings Län contributes healthcare system expertise and serves as a pilot region for eHealth monitoring implementation in cancer care.
• Region VästerbottencoreStrategic or Co-development Partner · 8 April 2021Partner in the PACE project alongside Tamro, Region Jönköpings Län, Linköpings Universitet, Lif, and ScientificMed. Contributes northern Sweden healthcare perspective to eHealth monitoring in cancer care.
• Linköpings UniversitetcoreStrategic or Co-development Partner · 8 April 2021Academic partner in the PACE Vinnova project led by Tamro. Contributes research expertise in health technology and eHealth to the cancer self-monitoring initiative.
• Lif (Läkemedelsindustriföreningen)coreStrategic or Co-development Partner · 8 April 2021Swedish pharmaceutical industry association partner in the PACE project. Lif supports with industry perspective and networking across research-based pharmaceutical companies in Sweden.
• PHOENIX GroupcoreOthers · 1 January 2021Tamro is owned by the German PHOENIX Group, a leading European healthcare provider active in 27 countries with over 40,000 employees and 158+ distribution centers across Europe. PHOENIX Group provides strategic oversight, group policies, and European-wide procurement advantages.
• Blue Ocean Sales Scandinavia ABminorStrategic or Co-development Partner · 1 July 2019Tamro AB acquired Blue Ocean Sales Scandinavia AB on July 1, 2019. Blue Ocean Sales offers marketing and sales services to suppliers on the Swedish pharmacy market. The acquisition strengthens Tamro's service offering to the pharmacy market. Blue Ocean Sales continues operating independently with headquarters in Stockholm.

Scale indicators8 records

Recent moves7 records

Expansion highlights7 records

Broad incumbents

• McKesson Corporation: Global pharmaceutical distribution and healthcare services leader. Operates overlapping pharma logistics and distribution capabilities but at vastly larger scale and with broader service portfolio than Tamro.
• Cardinal Health: Major US-based pharmaceutical distributor with global operations. Comparable core pharmaceutical distribution business but operates at multi-continent scale versus Tamro's Sweden-only footprint.
• Celesio: European pharmaceutical distribution and pharmacy operator, now part of McKesson. Comparable pharmaceutical wholesale capabilities across Europe but operating at significantly larger scale and broader geographic footprint than Tamro.
• Alliance Healthcare: European pharmaceutical wholesaler and distributor owned by Walgreens Boots Alliance, operating across multiple European countries. Comparable pharma distribution capabilities but broader geographic and portfolio scope than Tamro's Sweden-only focus.
• Phoenix Group: Tamro's parent company and Europe's largest pharmaceutical distributor, operating in 27 countries with 158+ distribution centers. Parent-level peer whose pan-European scale and procurement platform directly shape Tamro's competitive context.

Direct peers

• Mediq: European distributor of medical devices and pharmaceuticals with direct-to-customer and care-provider logistics. Closely comparable distribution model serving healthcare providers across multiple European markets.
• Oriola Corporation: Finnish pharmaceutical distributor operating a comparable dose-dispensing and pharmacy distribution model across the Nordics. Closest geographic and structural peer to Tamro with similar manufacturer-to-pharmacy logistics and adjacent health-tech services.
• NMD (Norsk Medisinaldepot): Norwegian pharmaceutical wholesaler and distribution company serving the Norwegian pharmacy market. Closest Nordic national-market peer to Tamro with directly comparable DTP-style logistics and GDP-compliant operations.

Others

• DHL Supply Chain (Life Sciences & Healthcare): Global contract logistics provider with dedicated life sciences and healthcare capabilities. Competes for outsourced pharma 3PL contracts in adjacent geographies and capability segments but does not serve the Swedish pharmacy channel directly.
• CEVA Logistics (Healthcare): Global logistics provider with healthcare and pharma-certified operations. Adjacent enabling player in pharmaceutical contract logistics but not a direct Sweden-pharmacy competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCK9jTSNQlsoFQauDWefSL_g
• LinkedInse.linkedin.com/company/tamro-sweden

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tamro